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Background: Visceral fat, including epicardial fat (EF) is recognized as a responsible factor of cardiovascular disease.
The aim of this study was to investigate the relationship between EF and diabetes in Korean men.
Methods: EF thickness was measured in the left main coronary artery fat tissue (LMCA-fat) by low-dose chest CT
scans in 1,048 Korean men (age above 20 years). LMCA-fat values were divided into quartiles and the prevalence of
diabetes was analyzed based on the quartiles of LMCA-fat values using logistic regression.
Results: There were significant correlations between LMCA-fat and body mass index (r = 0.169, p = 0.004), waist
circumference (r = 0.172, p < 0.001), fasting glucose (r = 0.106, p = 0.037) and HbA1c (r = 0.176, p < 0.001). The patients in
the higher LMCA-fat quartiles were associated with higher prevalence of diabetes (p for trend <0.001). Even after
adjustment for multiple covariates, this association still remained statistically significant (p for trend = 0.022). The
highest LMCA-fat quartile group was significantly associated with diabetes compared to the lowest quartile
group. (OR = 3.26, 95% CI = 1.17-9.12).
Conclusion: These findings indicate that increased EF thickness is independently associated with the prevalence
of diabetes in Korean men.
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Obesity and insulin resistance are important risk factors
of diabetes and atherosclerosis [1]. In particular visceral
fat is known to influence insulin resistance and the inci-
dence of diabetes. Therefore, visceral fat has been found
to be an independent risk factor of metabolic syndrome,
diabetes, and cardiovascular diseases [2]. Thus, recent
studies have shown that the visceral fat might have a
role in the pathogenesis of cardiovascular disease. How-
ever, most studies on visceral fat focus on the abdominal
area only. In fact, studies on the association of visceral
fat in other regions of the body with diabetes are
insufficient.
Epicardial fat (EF) is defined as the adipose tissue
enclosed in the visceral pericardium including the fat
surrounding coronary arteries [3]. EF originates from
brown fat and has the same origin as visceral fat, which* Correspondence: fmewha@naver.com
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visceral fat [4]. Also EF secretes pro-inflammatory and
anti-inflammatory cytokines and chemokines that
directly contacts the surroundings of the coronary artery
[3]. Although EF accounts for only 1% of total body fat,
it has been suggested to influence the development of
coronary atherosclerosis due to its endocrine and para-
crine activities. Therefore, interest in EF is on the rise.
Visceral fat, especially EF has been shown to have close
correlation with insulin resistance [5]. For that reason,
EF could be a major factor that influences metabolic
diseases such as metabolic syndrome and cardiovascular
diseases such as coronary artery disease. Several studies
have reported the correlation between EF and insulin
resistance [6-12]. Based on these study results, the
hypothesis that EF may contribute to unfavorable meta-
bolic risk profiles has been suggested [11].
Low dose chest computed tomography (LDCT) is a
useful tool for lung cancer screening in health promo-
tion centers. LDCT is frequently used these days due to
the advantage that it does not require 6 hour fasting andhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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the contrast-enhanced computed tomography (CT). EF
thickness area and volume can be accurately measured
by LDCT [4]. Among them, EF thickness can be most
easily measured, has little difference in repeated meas-
urement and EF thickness shows close correlation with
the total EF volume [13]. Recently, many researchers
have been interested in EF thickness and many studies
were done. Although EF is distributed asymmetrically
between the coronary artery and ventricle or between
the ventricles, there were no differences by the measure-
ment methods (ultrasonography or 3-dimensional heart
computed tomography) in the thickness of EF in previ-
ous studies [14-16]. EF thickness can be measured at the
level of the three main coronary arteries (right, left an-
terior descending and left circumflex arteries) or at the
right ventricular free wall [4]. EF thickness, especially
measured around the left main coronary artery-fat
(LMCA-fat) has been used in many studies since it can
be most simply measured using just few image slices. In
this study, we investigate the association of LDCT-
measured LMCA-fat thickness with the prevalence of
type 2 diabetes in Korean men.
Method
Study population
The present study was a retrospective cross-sectional
study to examine the association between EF and
prevalence of diabetes in Korean men participating in a
medical health check-up program at the health promo-
tion center of Ewha Womans University School of
Medicine Seoul, Korea. The subjects of this study were
1,101 adult males aged 20 or older who received LDCT
scans for lung cancer screening between January 2011
and June 2012. Diabetes was defined as fasting blood
glucose of more than 126 mg/dL, or HbA1c value of
more than 6.5%, or current use of oral hypoglycemic
agents or insulin [17]. Among the 1,101 participants, 53
men who had history of malignancy or cardiovascular
disease and whose presence of diabetes could not be
determined were excluded from the study. Accordingly,
1,048 participants were included in the final analysis.
This study was approved by the Institutional Review
Board of Ewha Woman's University Mokdong Hospital
(IRB file number: EUMC 2014-05-022-001). Informed
consent was obtained from all participants.
Study method
Study data included medical history physical examination,
information provided by questionnaires, anthropometric
measurements and laboratory measurements. Medical
history was assessed by the examining physicians. All the
participants were asked about health-related behaviors
including alcohol consumption and smoking. Questionsabout alcohol consumption included frequency of alcohol
intake per week and usual amount of alcohol intake per
day. Participants were considered as current smokers
when reported to have smoked within the last six months,
and nonsmokers when reported to have not smoked for
the last six months or who have never smoked [18]. Their
heights were measured down to the 0.1 cm unit with the
subjects wearing a light gown for health examination, with
their heels attached to the ground, and their back straight-
ened. Their weights were measured wearing a light gown
of less than 0.1 kg, after an overnight 8 hour fasting and
after urination. Body mass index (BMI) was defined as
their weight (kg) divided by the square of their height (m).
Waist circumference (WC) was measured down to the
0.1 cm unit at the midpoint between the lower rib margin
and the iliac crest. After resting for at least 5 minutes,
blood pressures were measured using a standardized
mercury sphygmomanometer at the right brachial artery
while sitting on a chair. Systolic blood pressure (SBP) and
diastolic blood pressure (DBP) were recorded as the first
and fifth Korotkoff phases, respectively. The definition of
hypertension followed those of NCEP ATPIII, JNC 8
(The Eighth Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure). According to the JNC-8 guidelines,
hypertension was defined as cases of a systolic blood
pressure of 140 mmHg or higher or a diastolic blood
pressure of 90 mmHg or higher which were measured
during the health examination or taking antihypertensive
agent after being diagnosed with hypertension [19]. If the
blood pressure was abnormal at first measurement, they
were measured once more after resting for 10 minutes
and the latter blood pressure was used as study data.
Laboratory measure
For the blood tests peripheral venous samples were
collected after fasting for at least 8 hours. Total choles-
terol, triglyceride (TG), low density lipoprotein (LDL)
cholesterol, high density lipoprotein (HDL) cholesterol,
aspartate aminotransferase (AST), alanine aminotransferase
(ALT), gamma galutamyltransferase (GGT), creatinine,
fasting blood glucose, and hemoglobin A1c (HbA1c) were
measured. These levels were measured using Bayer Reagent
Packs (Bayer HealthCare, Tarrytown, NY, USA) with an
automated chemistry analyzer (ADVIA 1650 Autoanalyzer
Bayer Diagnostics Leverkusen, Germany). The clinical
laboratory has been accredited and participates annually in
inspections and surveys done by the Korean Association of
Quality Assurance for Clinical Laboratories.
LMCA-fat thickness measurement
In this study LDCT scan was taken using a 128 multi-
detector CT scanner (SOMATOM Definition Flash 128,
Siemens Medical Solution, Forchheim, Germany). Each
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thickness of each slice was 2 mm, average scan
duration was 4–6 seconds and the tube voltage was
low dose (120 kVp, 20 eff.mAs). EF was defined as
adipose tissue between the surface of the myocardium
and the visceral layer of the pericardium. The LMCA-
fat thickness was measured at the longest vertical
length of EF around the left main coronary artery at
the origin and was measured by the same doctor.
Since a single slice image is 2 mm in thickness, the
longest length of LMCA-fat thickness was measured
by looking at approximately 15 slices around the
LMCA. LMCA-fat thickness was measured manually
by one doctor and fat pixels were identified using
threshold attenuation values of −30 to −200 HU [20].
Statistical analysis
Data in the text and tables were expressed as mean ±
standard deviation (SD) or medians (interquartile range)
for continuous variables and percentages of the number
for categorical variables. Participants were divided into
quartiles on the basis of LMCA-fat thickness as follows:
quartile 1 (Q1) LMCA-fat thickness < 12.3 mm; quartile 2
(Q2) LMCA-fat thickness 12.3 to 15.4 mm quartile 3 (Q3)
LMCA-fat thickness 15.4 to 18.7 mm; and quartile 4 (Q4)
LMCA-fat thickness ≥ 18.7 mm. One-way ANOVA and
χ2-test were performed to analyze the statistical differences
among the characteristics of the participants according to
the quartile groups of LMCA-fat thickness. To analyze the
correlation between LMCA-fat thickness and the related
variables, Pearson correlation analysis was performed.
Linear-by-linear association was used to analyze the differ-
ences in the prevalence of diabetes by LMCA-fat thickness
quartiles with p for trend. Compared to the lowest quartile
of LMCA-fat thickness, the Odds ratios (ORs) of the
highest 3 quartiles of LMCA-fat thickness were calculated
using logistic regression. Also, logistic regression was used
to analyze the independent risk of LMCA-fat thickness on
diabetes after adjusting the clinical variables related to
diabetes such as age, BMI, SBP, DBP, AST, ALT, TG, HDL
cholesterol, and LDL cholesterol. PASW Statistics version
18.0 for Windows (SPSS Inc., Chicago, IL, USA) was used
for statistical analyses. P values of less than 0.05 were
considered to be statistically significant in every analysis.
Results
The demographic and biochemical characteristics of
the participants according to type 2 diabetes are pre-
sented in Table 1. Among the total of 1,048 subjects
13.5% (141 participants) were found to have diabetes.
The mean age of study participants was 41.3 ± 6.3 years,
20.7% (217 participants) were current smokers and
17.8% (187 participants) were patients with hyperten-
sion. The mean BMI and WC of study participantswere 24.9 ± 7.3 kg/m2 and 88.4 ± 5.6 cm, respectively.
Participants with diabetes were older, more obese,
smokers, had higher blood pressure and unhealthy
laboratory findings. In these two groups, there were no
significant differences in total cholesterol and LDL
cholesterol. LMCA fat thickness in the diabetes group
(17.6 ± 6.7 mm) was significantly higher than in the
non-diabetes group (14.4 ± 5.9 mm) (p < 0.001).
Table 2 shows clinical characteristics according to the
quartile groups of LMCA-fat thickness. As expected age,
hypertension, BMI, WC, and blood pressure of the par-
ticipants tended to increase according to the quartile
groups. The prevalence of diabetes also tended to in-
crease according to the quartile groups of LMCA-fat
thickness level (p < 0.001). All clinical variables showed
statistically significant differences between the four
groups except for recent smoking status. The higher
LMCA quartiles had less favorable metabolic profiles. In
the laboratory findings, there were significant linear
trends across the quartiles of LMCA except for total
cholesterol and LDL-cholesterol. Age, prevalence of
hypertension, BMI, WC, blood pressure, AST, ALT,
GGT, Triglyceride, fasting glucose, HDL cholesterol and
HbA1c tended to increase as the LMCA fat thickness
level increased. Differences in the prevalence of diabetes
were examined through p for trend analysis according to
the LMCA-fat thickness quartiles and are presented at
the bottom of Table 2. A total of 141 men were identi-
fied to have diabetes by fasting glucose, HbA1c and
medical history among the 1,048 participants. When the
LMCA fat thickness was divided into four quartiles, the
prevalence of diabetes was 6.9% (18 participants) in
quartile 1, 9.5% (25 participants) in quartile 2, 16.4% (43
participants) in quartile 3 and 21.3% (55 participants) in
quartile 4. In other words, there was a significant linear
trend in the prevalence of diabetes across the quartiles
of LMCA-fat thickness level. As expected, the preva-
lence of diabetes tended to increase depending on the
LMCA fat thickness (p for trend < 0.001).
To analyze the correlation between LMCA fat thickness
and the related variables a Pearson correlation analysis was
performed (Table 3). LMCA fat thickness correlated with
BMI (r = 0.169, p = 0.004) and WC (r = 0.172, p < 0.001).
Fasting glucose (r = 0.105, p = 0.037) and HbA1c (r = 0.176,
p < 0.001) showed significant positive correlation with the
LMCA fat thickness. Age, blood pressure and most la-
boratory findings except for fasting glucose and HbA1c
did not have significant correlations with LMCA fat
thickness.
The unadjusted OR of diabetes were 1.43 (95% CI = 0.76-
2.69) in quartile 2 2.66 (95% CI = 1.49-4.75) in quartile 3
and 3.69 (95% CI = 2.10-6.47) in quartile 4 compared to
quartile 1 (Table 4). Even after adjustment for age, BMI,
WC, TG, systolic BP, GGT, ALT, smoking status and
Table 1 Baseline characteristics of the study population (n = 1,048)
Variable Overall (n = 1,048) Diabetes (n = 141) Non-diabetes (n = 907) p value*
Age 41.3 ± 6.3 44.1 ± 7.1 40.25 ± 6.9 <0.001
Smoker (%) 217 (20.7) 39 (27.7) 178 (19.6) <0.001
Hypertension (%) 187 (17.8) 37 (26.2) 150 (16.5) <0.001
BMI (kg/m2) 24.9 ± 7.3 26.1 ± 5.7 23.7 ± 2.8 <0.001
WC (cm) 88..4 ± 5.6 91.2 ± 6.1 86.5 ± 7.5 <0.001
SBP (mmHg) 125.3 ± 12.4 126.1 ± 10.5 124.8 ± 11.4 0.024
DBP (mmHg) 75.4 ± 9.6 77.2 ± 10.1 75.1 ± 10.0 <0.001
AST (IU/L) 24.7 ± 7.9 26.2 ± 8.5 24.2 ± 6.5 0.007
ALT (IU/L) 26.2 ± 8.1 27.5 ± 7.1 25.6 ± 9.4 0.006
GGT(IU/L) 41.5 ± 8.5 43.6 ± 8.2 40.2 ± 10.1 <0.001
Total cholesterol (mg/dL) 189.7 ± 29.5 190.1 ± 28.7 189.6 ± 30.8 0.751
Triglyceride (mg/dL) 127.6 ± 24.9 131.7 ± 25.1 127.1 ± 19.9 <0.001
HDL-C(mg/dL) 48.4 ± 10.4 48.0 ± 9.8 49.6 ± 11.1 0.021
LDL-C (mg/dL) 119.3 ± 30.3 120.4 ± 29.2 119.1 ± 33.5 0.252
Fasting glucose (md/dL) 97.5 ± 20.1 103.8 ± 21.5 96.1 ± 25.4 <0.001
HbA1c (%) 5.9 ± 1.1 6.3 ± 1.2 5.7 ± 0.9 <0.001
LMCA fat (mm) 14.9 ± 5.3 17.6 ± 6.7 14.4 ± 5.9 < 0.001
*P value was calculated by ANOVA or chi-square test.
Abbreviation: LMCA. left main coronary artery fat distance measured by low dose chest CT, DM, diabetes mellitus.
Table 2 Clinical characteristics of the study population and LMCA fat quartile
Variable LMCA fat quartile p value*
Q1 Q2 Q3 Q4
Age (years) 36.9 ± 9.5 40.5 ± 9.2 42.6 ± 9.8 43.4 ± 10.3 <0.001
Smoker (%) 51 (19.7) 47 (18.1) 39 (15.6) 80 (30.6) 0.091
Hypertension (%) 34 (12.9) 41 (15.5) 53 (20.4) 59 (22.4) 0.001
BMI (kg/m2) 23.4 ± 3.9 24.7 ± 4.2 25.3 ± 3.8 26.0 ± 3.1 0.014
WC (cm) 87.4 ± 5.9 88.1 ± 6.7 88.9 ± 6.5 90.6 ± 7.1 <0.001
SBP (mmHg) 122.6 ± 12.1 125.1 ± 12.2 125.6 ± 11.6 127.7 ± 12.2 <0.001
DBP (mmHg) 74.4 ± 9.3 75.6 ± 10.2 76.9 ± 10.0 78.3 ± 9.5 <0.001
AST (IU/L) 22.3 ± 7.3 23.5 ± 8.1 25.2 ± 6.9 26.4 ± 7.9 0.004
ALT (IU/L) 22.4 ± 8.2 25.5 ± 7.5 27.1 ± 9.0 27.3 ± 8.3 0.010
GGT(IU/L) 31.6 ± 9.3 36.3 ± 8.6 43.5 ± 10.1 45.2 ± 11.3 <0.001
Total cholesterol (mg/dL) 188.7 ± 33.8 191.3 ± 31.7 187.6 ± 34.8 190.4 ± 35.9 0.901
Triglyceride (mg/dL) 106 ± 21.9 116 ± 23.1 130 ± 19.4 128 ± 21.3 <0.001
HDL-C(mg/dL) 51.5 ± 11.4 49.8 ± 10.4 48.6 ± 11.5 49.5 ± 11.0 0.017
LDL-C (mg/dL) 121.3 ± 32.3 123.4 ± 29.1 119.1 ± 33.1 119.3 ± 33.6 0.214
Fasting glucose (md/dL) 90.2 ± 21.8 93.8 ± 20.9 96.2 ± 22.1 97.5 ± 18.6 <0.001
HbA1c (%) 5.8 ± 1.0 5.9 ± 0.9 6.0 ± 0.8 6.1 ± 0.8 0.002
Diabetes (%) 18 (6.9) 25 (9.5) 43 (16.4%) 55 (21.3%) <0.001
*P value was calculated by ANOVA or chi-square test.
Data are presented as mean ± standard deviation.
LMCA fat: left main coronary artery fat distance measured by low dose chest CT; BMI: Body mass index; WC: Waist circumference; SBP: systolic blood pressure;
DBP: diastolic blood pressure; AST: asparatate transaminase; ALT: alanine aminotransferase; GGT: gamma galutamyl transferase; HDL-C: high density lipoprotein
cholesterol; LDL-C: low density lipoprotein cholesterol; HBA1c: hemoglobin A1c; DM: diabetes mellitus.
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Fasting glucose 0.106 0.037
HbA1c 0.176 <0.001
*r means pearson correlation coefficient.
† P value was calculated by pearson correlation.
LMCA fat: left main coronary artery fat distance measured by low dose chest
CT; BMI: body mass index; WC: waist circumference; SBP: systolic blood
pressure; DBP: diastolic blood pressure; AST: asparatate transaminase; ALT:
alanine aminotransferase; GGT: gamma galutamyl transferase; HDL-C: high
density lipoprotein cholesterol: LDL-C: low density lipoprotein; HBA1c:
hemoglobin A1c.
Table 4 Odds ratio of diabetes according to LMCA fat
quartile*
Odds ratio ( 95% Confidence Interval)
Unadjusted Multivariate-adjusted model†
LMCA
Quartile 1 1.00 (reference) 1.00 (reference)
Quartile 2 1.43 (0.76-2.69) 1.63 (0.57-4.65)
Quartile 3 2.66 (1.49-4.75) 1.51 (0.52-4.39)
Quartile 4 3.69 (2.10-6.47) 3.26 (1.17-9.12)





Systolic BP 1.02 (1.00-1.05)
GGT 1.00 (1.00-1.01)
ALT 1.00 (0.99-1.01)
Smoking status 1.93 (0.82-4.54)
Alcohol intake 1.37 (0.52-3.62)
*Data are given as odds ratio (95% confidence intervals) by logistic
regression analysis.
† Multivaiate data are adjusted by age, BMI, Triglyceride, systolic BP, GGT, ALT,
smoking status and alcohol intake.
LMCA fat: left main coronary artery fat distance measured by low dose chest
CT; 95% CI:95% confidence intervals; BMI: body mass index; WC: waist
circumference; BP: blood pressure; GGT: gamma galutamyl transferase; ALT:
alanine aminotransferase.
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showed statistically significant higher levels compared with
quartile 1. But after adjustment for the above mentioned
factors, the OR of diabetes were 1.63 (95% CI = 0.57-4.65)
in quartile 2 and 1.51 (95% CI = 0.52-4.39) in quartile 3, re-
spectively. However, we saw that increased LMCA fat
thickness was significantly associated with higher odds of
type 2 diabetes (p for trend = 0.022).Discussion
Main results
The result of this study showed significant association
between LMCA fat thickness and the prevalence of
diabetes in Korean men. In this study the prevalence
of diabetes was increased in a dose-dependent manner
by increasing quartiles of LMCA-fat thickness (p for
trend < 0.001). In other words, the prevalence of
diabetes increased as the EF thickness increased.
According to the quartiles of LMCA fat thickness, the
prevalence of diabetes in quartile 2, quartile 3, and
quartile 4 were 1.43 times, 2.66 times, and 3.69 times
higher respectively, than that of quartile 1 which has
the lowest EF thickness. This indicates that the in-
crease of EF thickness is associated with the increase
of diabetes prevalence. This association persisted after
adjusting for age, BMI, WC, TG, SBP, GGT, ALT,smoking status and alcohol intake in quartile 4 which
has the highest EF thickness.
Potential mechanisms
The relationship between EF and diabetes can be ex-
plained in a few ways. First EF is the visceral fat
surrounding the heart and is closely correlated with
abdominal fat [21]. The relationship can be explained
with by the developmental process of the fetus [5].
Both EF and abdominal fat seem to originate from
brown fat which has less anti-lipolytic effect of insulin.
Thus, EF is expected to have the same biochemical
characteristics as abdominal fat and play a key role in
the pathogenesis of diabetes and insulin resistance [7].
EF thickness was shown to be significantly and inde-
pendently associated with left ventricular diastolic
dysfunction and inflammation in patients undergoing
peritoneal dialysis and these associations might act
synergistically in the pathogenesis of unfavorable
metabolic profiles [22]. Moreover, it is known that EF
secretes inflammation-related materials such as tumor
necrosis factor-alpha (TNF-α), interleukine-6 (IL-6),
free fatty acids (FFA), plasminogen activator inhibitor-1
(PAI-1) and adiponectin into blood vessels, especially
the coronary arteries, thereby influencing diabetes,
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the coronary arteries might secrete adipokines such as
adiponectin from ‘outside-to-inside’ into the intima-
media layer of blood vessels, thereby contributing to
inflammation, atherosclerosis and insulin resistance.
Considering the circulation system of our body, it is
possible to explain that inflammatory cytokines will be
delivered to the whole body because the heart supplies
blood to the whole body. Increased plasma concentra-
tions of TNF-α, IL-6, FFA, and PAI-1 and decreased
concentrations of adiponectin may lead to accelerated
atherosclerosis, plaque instability, and arterial throm-
bosis. Interestingly, a recent study has shown that
FABP4 (Fatty acid-binding proteins 4) expressed in
adipocytes or macrophages via classical secretion of
numerous inflammation–related materials act as an
adipokine for the development of insulin resistance
[24]. In addition, it has been shown that higher retinol-
binding protein 4 (RBP4) and lower glucose transporter
4 (GLUT4) might contribute to an unfavorable meta-
bolic condition including insulin resistance [25]. RBP4
as an adipokine has been shown to induce insulin
resistance and GLUT4 to mediate insulin-stimulated
glucose uptake in EF. These inflammatory substances
of EF are thought to have significant inflammatory and
proatherogenic effects. Up to date, studies are not able
to reveal the direct effects of EF on cardiovascular
diseases and diabetes.
Comparision with other studies
Several studies have reported of the association between
the EF surrounding coronary arteries and heart and the
development of metabolic syndrome and coronary
atherosclerosis. Petra M. Gorter et al. reported that epi-
cardial fat and pericoronary fat are associated with the
existence of obesity and metabolic syndrome in patients
with coronary artery disease [13]. Iacobelli G et al.
revealed that EF measured by transthoracicechocardio-
graphy could be a potential risk factor for explaining
fasting blood glucose disorder [21]. Although Iacobelli
G et al. showed limited results on the correlation
between EF and fasting blood glucose [21], our study is
meaningful in that the association between EF and the
prevalence of diabetes was examined directly. When
compared with other studies our study results show a
relatively low correlation between BMI and EF thickness
(r = 0.169, p value = 0.004). This may be due to the fact
that the participants were from health check-ups, so
they were much interested in their health and also to
the fact that they were relatively young. The reason that
other studies have shown a more higher association
with BMI may be due to the fact that in most studies
researchers investigated EF of patients with coronary
heart disease [8,9,13,17,26] or gestational diabetes [27].In contrast, some studies reported that EF was signifi-
cantly higher in patients with coronary artery disease or
left ventricular diastolic dysfunction but BMI had no
statistical significance. Despite this study being con-
sisted of more young and healthy people, we showed
significant association between EF thickness and the
prevalence of diabetes in Korean men after adjustment
for BMI and WC. This is meaningful in that the partici-
pants of our study were those without previous heart
diseases. The important point is that high EF was a
more important factor than high weight or high visceral
fat in healthy Korean men even though the correlation
coefficient r value was lower than other studies.
Limitations of this study
Nevertheless some limitations need to be taken into
account as well. First, the pathophysiological effect of
EF on predisposition to diabetes was not investigated.
In this cross-sectional study, we found the simple
correlation between EF and the prevalence of diabetes,
so we could not find the causal relationship between
them. Second, the study participants were limited to a
single institution. In addition, because we limited the
participants to those who received LDCT scan for a
medical health check-up, there can be a problem in
applying this result to the general population. Third,
this study confirmed the association between EF thick-
ness and diabetes but a volumetric analysis of EF was
not performed. Since volumetric analysis of EF is a
time consuming work and requires skilled operators
and a specific software program for semi-automated
measurement of EF volume, it is difficult to be easily
done. Besides, EF thickness shows close correlation
with the measurement of the total EF volume [13]. In
addition, it is important that we could measure EF
thickness in a very simple method without the help of
other software programs.
Conclusion
Our findings indicate that increased EF thickness – not
abdominal fat or total body fat - is independently asso-
ciated with the prevalence of diabetes in Korean men.
In addition, EF could be considered a marker for un-
favorable metabolic profile.
Abbreviations
AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; BMI: Body
mass index; CT: Computed tomography; DBP: Diastolic blood pressure;
EF: Epicardial fat; GGT: Γ-glutamyltransferase; HbA1c: Hemoglobin a1c;
HDL: High-density lipofpdlsprotein; LDCT: Low dose chest computed
tomography; LDL: Low-density lipoprotein; LMCA-fat: Left main coronary
artery fat; SBP: Systolic blood pressure; TG: Triglyceride; WC: Waist
circumference.
Competing interests
The authors declare that they have no competing interests.
Chun et al. Cardiovascular Diabetology  (2015) 14:46 Page 7 of 7Authors’ contributions
HC and KWS conceived the study, participated in its design and
coordination; HC and ES researched data, analyzed data and wrote the
manuscript; ARB analyzed data and participated and reviewed manuscript;
HRP participated in measurements of the epicardial adipose thickness.
All authors read and approved the final manuscript.
Acknowledgments
We the guarantors (HC and KWS) take full responsibility of this work as a
whole. No funding source is reported.
Author details
1Health Promotion Center, Ewha Womans University Mokdong hospital,
Ewha Womans University School of Medicine, Anyangcheon-ro,
Yangcheon-gu, Seoul 158-710, South Korea. 2Department of Family Medicine,
Chaum Hospital, CHA University, 4-1, Cheongdam-dong, Gangnam-gu, Seoul
135-948, South Korea. 3Departments of Family Medicine, Ewha Womans
University Mokdong hospital, Ewha Womans University School of Medicine,
1071, Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, South Korea.
Received: 5 February 2015 Accepted: 15 April 2015
References
1. Festa A, D'Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner SM.
Chronic subclinical inflammation as part of the insulin resistance syndrome:
the Insulin Resistance Atherosclerosis Study (IRAS). Circulation.
2000;102:42–7.
2. Arsenault BJ, Lachance D, Lemieux I, Almeras N, Tremblay A, Bouchard C,
et al. Visceral adipose tissue accumulation, cardiorespiratory fitness, and
features of the metabolic syndrome. Arch Intern Med. 2007;167:1518–25.
3. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al.
Human epicardial adipose tissue is a source of inflammatory mediators.
Circulation. 2003;108:2460–6.
4. Bertaso AG, Bertol D, Duncan BB, Foppa M. Epicardial fat: definition,
measurements and systematic review of main outcomes. Arq Bras Cardiol.
2013;101(1):e18–8.
5. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific
hormonal characteristics of subcutaneous and visceral adipose tissue and
their relation to the metabolic syndrome. Horm Metab Res. 2002;34:616–21.
6. Perseghin G, Lattuada G, De Cobelli F, Esposito A, Belloni E, Ntali G, et al.
Increased mediastinal fat and impaired left ventricular energy metabolism in
young men with newly found fatty liver. Hepatology. 2008;47(1):51–8.
7. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Mario U, et al.
Epicardial fat from echocardiography: a new method for visceral adipose
tissue prediction. Obes Res. 2003;11(2):304–10.
8. Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK, et al. Echocardiographic
epicardial fat thickness and coronary artery disease. Circ J. 2007;71(4):536–9.
9. Ahn SG, Lim HS, Joe DY, Kang SJ, Choi BJ, Choi SY, et al. Relationship of
epicardial adipose tissue by echocardiography to coronary artery disease.
Heart. 2007;94(3), e7.
10. Iacobellis G, Pellicelli AM, Sharma AM, Grisorio B, Barbarini G, Barbaro G.
Relation of subepicardial adipose tissue to carotid intima-media thickness in
patients with human immunodeficiency virus. Am J Cardiol.
2007;99(10):1470–2.
11. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with
cardiovascular disease. Nature. 2006;444(7121):875–80.
12. Chaowalit N, Somers VK, Pellikka PA, Rihal CS, Lopez-Jimenez F. Subepicardial
adipose tissue and the presence and severity of coronary artery disease.
Atherosclerosis. 2006;186(2):354–9.
13. Saremi F, Mekhail S, Sefidbakht S, Thonar B, Malik S, Sarlaty T. Quantification
of epicardial adipose tissue: correlation of surface area and volume
measurements. Acad Radiol. 2011;18(8):977–83.
14. Gorter PM, van Lindert AS, de Vos AM, Meijs MF, van der Graaf Y,
Doevendans PA, et al. Quantification of epicardial and peri-coronary fat
using cardiac computed tomography; reproducibility and relation with
obesity and metabolic syndrome in patients suspected of coronary artery
disease. Atherosclerosis. 2008;197(2):896–903.
15. Abbara S, Desai JC, Cury RC, Butler J, Nieman K, Reddy V. Mapping epicardial
fat with multi-detector computed tomography to facilitate percutaneous
transepicardial arrhythmia ablation. Eur J Radiol. 2006;57(3):417–22.16. Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS,
et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk
factors, and vascular calcification in a community-based sample: the
framingham heart study. Circulation. 2008;117(5):605–13.
17. American Diabetes Association. Standards of medical care in diabetes.
Diabetes Care. 2015;38 supp:S4.
18. Stem MP, Williams K, Gonzalez-Villapando C, Hunt KJ, Haffiner SM. Does the
metabolic syndrome improve identification of individuals at risk of type 2
diabetes and/or cardiovascular disease? Diabetes care. 2004;27(11):2676–81.
19. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C,
Handler J, et al. Evidence-based guideline for the management of high
blood pressure in adults: report from the panel members appointed to
the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20.
20. Nakazato R, Shmilovich H, Tamarappoo BK, Cheng VY, Slomka PJ, Berman
DS, et al. Interscan reproducibility of computer-aided epicardial and
thoracic fat measurement from noncontrast cardiac CT. J Cardiovasc
Comput Tomogr. 2011;5(3):172–9.
21. Iacobellis G, Barbaro G, Gerstein HC. Relationship of epicardial fat thickness
and fasting glucose. Int J Cardiol. 2008;128(3):424–6.
22. Lin HH, Lee JK, Yang CY, Lien YC, Huang JW, Wu CK. Accumulation of
epicardial fat rather than visceral fat is an independent risk factor for left
ventricular diastolic dysfunction in patients undergoing peritoneal dialysis.
Cardiovasc Diabetol. 2013;12:127.
23. Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, et al.
Adiponectin expression in human epicardial adipose tissue in vivo is lower
in patients with coronary artery disease. Cytokine+. 2005;29(26):251–5.
24. Fuseya T, Furuhashi M, Yuda S, Muranaka A, Kawamukai M, Mita T, et al.
Elevation of circulating fatty acid-binding protein 4 is independently associated
with left ventricular diastolic dysfunction in a general population. Cardiovasc
Diabetol. 2014;13:126.
25. Salgado-Somoza A, Teijeira-Fernández E, Rubio J, Couso E, González-Juanatey
JR, Eiras S. Coronary artery disease is associated with higher epicardial retinol-
binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in
epicardial and subcutaneous adipose tissue. Clin Endocrinol (Oxf).
2012;76(1):51–8.
26. Kohichiro I, Takeshi M, Hitoshi A, Hiroshi F, Masanobu S. Relationship between
epicardial fat measured by 64-multidetector computed tomography and
coronary artery disease. Clin Cardiol. 2011;34(3):166–71.
27. Gökay N, Sinan I, Gökhan A, Oguz KU, Rukiye N, Korhan S. The relationship
between epicardial fat thickness and gestational diabetes mellitus. Diabetol
Metab Syndr. 2014;6(1):120.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
